| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/21/2008 | US20080041370 Aerosol formulation for the inhalation of beta agonists |
| 02/21/2008 | US20080041369 Aerosol formulation for the inhalation of beta agonists |
| 02/21/2008 | US20080041367 NMDA Receptor Antagonist Formulation With Reduced Neurotoxicity |
| 02/21/2008 | DE202007015417U1 Präparat zur Bekämpfung von Herpes labialis, Herpes vaginalis, Psoriasis, Schmerzen von Verbrennungen 1.ten und 2.ten Grades, infizierten Hautpartien und Neurodermitis 1.ten preparation to combat herpes labialis, herpes vaginalis, psoriasis, pain from burns and 2.ten degree, infected skin and eczema |
| 02/21/2008 | DE202007003896U1 Pharmazeutische Zusammensetzung zur Behandlung von Inkontinenz A pharmaceutical composition for the treatment of incontinence |
| 02/21/2008 | DE202004021379U1 Kristalline Formen von Pitivastatin Calcium Crystalline forms of calcium Pitivastatin |
| 02/21/2008 | DE102007004991A1 Use of biocomplex preparation (from reaction pattern in vertebrate cells) for the treatment of apoplexia and acute circulatory disorders |
| 02/21/2008 | DE102006039038A1 Neues Herstellungsverfahren New manufacturing process |
| 02/21/2008 | DE102006039003A1 Neue Verbindungen New connections |
| 02/21/2008 | DE102006038403A1 Verwendung bestimmter chemischer Verbindungen zur Inhibierung der Peptidyl-Prolyl-cis/trans-Isomeraseaktivität von Cyclophilinen The use of certain chemical compounds for inhibition of the peptidyl-prolyl cis / trans isomerase activity of cyclophilins |
| 02/21/2008 | DE102006038292A1 Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen Transdermal application of triazines of combating coccidia infections |
| 02/21/2008 | DE102006037580A1 Sandel-Duftstoffrezeptoren Sandalwood scent receptors |
| 02/21/2008 | CA2696021A1 Macrocyclic compounds useful as inhibitors of kinases and hsp90 |
| 02/21/2008 | CA2691467A1 Cholesterol lowering drug combination |
| 02/21/2008 | CA2675244A1 Milnacipran for the treatment of cognitive dysfunction associated with fibromyalgia |
| 02/21/2008 | CA2665933A1 Compositions and methods for inhibiting cytochrome p450 |
| 02/21/2008 | CA2661580A1 Novel salts of the active substance rasagiline |
| 02/21/2008 | CA2661293A1 Combination treatment for metabolic disorders |
| 02/21/2008 | CA2661093A1 Dicer substrate rna peptide conjugates and methods for rna therapeutics |
| 02/21/2008 | CA2661085A1 Combination faah inhibitor and analgesic, anti-inflammatory or anti-pyretic agent |
| 02/21/2008 | CA2661082A1 Benzo[1,2,3]thiadiazine derivatives |
| 02/21/2008 | CA2661064A1 Pharmaceutical formula for treating skin disease |
| 02/21/2008 | CA2661023A1 Prlr-specific antibody and uses thereof |
| 02/21/2008 | CA2661018A1 Synthesis of propyl phenoxy ethers and use as delivery agents |
| 02/21/2008 | CA2661006A1 Crystalline and amorphous forms of tiagabine |
| 02/21/2008 | CA2661003A1 Crystalline forms of tiagabine hydrochloride |
| 02/21/2008 | CA2660994A1 Substituted acetylenic compounds useful for the treatment of diseases |
| 02/21/2008 | CA2660991A1 Compositions comprising calcium citrate malate and methods for making the same |
| 02/21/2008 | CA2660974A1 Modulators of muscarinic receptors |
| 02/21/2008 | CA2660911A1 Thiourea compounds |
| 02/21/2008 | CA2660903A1 Modulators of muscarinic receptors |
| 02/21/2008 | CA2660902A1 Methods for reducing toxicities associated with medical procedures employing radiographic contrast agents |
| 02/21/2008 | CA2660899A1 Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders |
| 02/21/2008 | CA2660890A1 3,4-dihydrobenzo[1,2,3]thiadiazine-1,1-dioxide derivatives, process for preparation thereof, medicaments containing said derivatives and their use |
| 02/21/2008 | CA2660880A1 Treatment of inflammatory diseases |
| 02/21/2008 | CA2660836A1 Triazolotriazines as kinase inhibitors |
| 02/21/2008 | CA2660799A1 Pyrrolo[2,1-c][1,4]benzodiazepine hybrids and a process for the preparation thereof |
| 02/21/2008 | CA2660794A1 Ntetrahydropyridothiophene derivatives for the treatment of cancer |
| 02/21/2008 | CA2660776A1 Apparatus and process for manufacturing food products with omega-3 polyunsaturated fatty acids |
| 02/21/2008 | CA2660762A1 Transdermal application of triazines for controlling infections with coccidia |
| 02/21/2008 | CA2660707A1 Preparation of (r,r)-fenoterol and (r,r)- or (r,s)-fenoterol analogues and their use in treating congestive heart failure |
| 02/21/2008 | CA2660659A1 Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects |
| 02/21/2008 | CA2660637A1 Phenylalkyl n-hydroxyureas for combating atherosclerotic plaque |
| 02/21/2008 | CA2660628A1 Hepatitis c virus inhibitors |
| 02/21/2008 | CA2660608A1 Therapeutic lactams |
| 02/21/2008 | CA2660604A1 Tetrahydrobenzothiophene derivatives |
| 02/21/2008 | CA2660560A1 Pyrazine compounds, their use and methods of preparation |
| 02/21/2008 | CA2660555A1 Viral polymerase inhibitors |
| 02/21/2008 | CA2660520A1 Hepatitis c virus inhibitors |
| 02/21/2008 | CA2660519A1 Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors |
| 02/21/2008 | CA2660516A1 Treating or preventing cancers over-expressing reg4 or kiaa0101 |
| 02/21/2008 | CA2660489A1 6-substituted isoquinoline derivatives as rock-1 inhibitors |
| 02/21/2008 | CA2660488A1 Aerosol formulation for the inhalation of beta agonists |
| 02/21/2008 | CA2660480A1 Aerosol formulation for the inhalation of beta agonists |
| 02/21/2008 | CA2660476A1 Formulations of flibanserin and method for manufacturing the same |
| 02/21/2008 | CA2660474A1 Arylpiperazine derivatives and uses thereof |
| 02/21/2008 | CA2660441A1 Imidazole amines as inhibitors of .beta.-secretase |
| 02/21/2008 | CA2660397A1 Pyrrolidinone anilines as progesterone receptor modulators |
| 02/21/2008 | CA2660396A1 Therapeutic amides and related compounds |
| 02/21/2008 | CA2660308A1 Therapeutic n-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives |
| 02/21/2008 | CA2660283A1 2-acylaminothiazole compositions and methods for increasing blood platlelet levels in humans |
| 02/21/2008 | CA2660204A1 Nucleic acid modulation of toll-like receptor-mediated immune stimulation |
| 02/21/2008 | CA2660056A1 Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders |
| 02/21/2008 | CA2660022A1 Protein matrix vaccines and methods of making and administering such vaccines |
| 02/21/2008 | CA2659928A1 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin ii receptor antagonists |
| 02/21/2008 | CA2659655A1 Salicylanilides enhance oral delivery of therapeutic peptides |
| 02/21/2008 | CA2659562A1 Stable lyophilized preparation |
| 02/21/2008 | CA2659425A1 Triazole compounds that modulate hsp90 activity |
| 02/21/2008 | CA2659424A1 Use of hppd inhibitors in the treatment of depression and/or withdrawal symptoms associated with addictive drugs |
| 02/21/2008 | CA2659299A1 Azetidine compounds |
| 02/21/2008 | CA2659276A1 2-amido-4-isoxazolyl thiazole compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 02/21/2008 | CA2659257A1 Organic nanoparticles and method of preparation thereof |
| 02/21/2008 | CA2659208A1 Oxazolidone derivatives as pr modulators |
| 02/21/2008 | CA2658984A1 Non-nucleoside reverse transcriptase inhibitors |
| 02/21/2008 | CA2658960A1 Phenyl, pyridine and quinoline derivatives |
| 02/21/2008 | CA2658843A1 Crystalline antifungal compounds |
| 02/21/2008 | CA2658725A1 Using pi3k and mek modulators in treatments of cancer |
| 02/21/2008 | CA2658475A1 Organic compounds |
| 02/21/2008 | CA2656847A1 Glucopyranosyl-substituted cyclopropylbenzene derivatives, pharmaceutical compositions containing such compounds, their use as sglt inhibitors and process for their manufacture |
| 02/21/2008 | CA2654050A1 Ionizable inhibitors of fatty acid amide hydrolase |
| 02/21/2008 | CA2650932A1 Substituted spirocyclic cgrp receptor antagonists |
| 02/21/2008 | CA2650206A1 Novel crystal of 5-aminolevulinic acid phosphate and process for producing the same |
| 02/21/2008 | CA2633112A1 A method of treating tumors with azaxanthones |
| 02/21/2008 | CA2629463A1 Imaging correlates of neurogenesis with mri |
| 02/20/2008 | EP1889911A2 An antisense oligonucleotide preparation method |
| 02/20/2008 | EP1889905A1 Method for amelioration of disease condition induced by mood disorder |
| 02/20/2008 | EP1889850A1 Novel triterpenic acid derivative and preparation for external application for skin comprising the same |
| 02/20/2008 | EP1889848A1 6,7-unsaturated-7-carbamoyl substituted morphinan derivative |
| 02/20/2008 | EP1889847A1 Pyrrolopyrimidines for pharmaceutical compositions |
| 02/20/2008 | EP1889846A1 Purine derivatives as A2a agonists |
| 02/20/2008 | EP1889845A1 Novel pleuromutilin derivatives |
| 02/20/2008 | EP1889844A2 Polymorphic forms of ziprasidone sulphates |
| 02/20/2008 | EP1889843A1 Bisheterocycle tandem compounds useful as antiviral agents, the uses thereof and the compositions comprising such compounds |
| 02/20/2008 | EP1889842A1 Heterocyclic compound |
| 02/20/2008 | EP1889841A1 Crystal of salt of benzimidazole compound |
| 02/20/2008 | EP1889839A1 Bicyclic compound, production and use as HIV inhibitors |
| 02/20/2008 | EP1889838A1 Thrombopoietin mimetics |
| 02/20/2008 | EP1889836A1 Novel pyridine derivative and pyrimidine derivative (3) |
| 02/20/2008 | EP1889835A1 Cyclic amine derivative having substituted alkyl group |
| 02/20/2008 | EP1889831A2 Diazenedicarboxamides as inhibitors of D-alanine: D-alanine ligase (Ddl) |